In the Summer, 2011 issue of MD Advisor, MD Advantage shares the results of a three-year trial of the PeriGen’s Shoulder Screen™ tool, a web-based application to identify mothers at greatest risk of shoulder dystocia. Using PeriCALM Shoulder Screen, MD Advantage’s insured physicians were able to reduce the incidence of shoulder dystocia by 50%, with no increase in the primary cesarean rate– disproving the myth that shoulder dystocia is an unpredictable and unpreventable occurrence. The article, “Shoulder Dystocia: Neither Predictable nor Preventable? Not Anymore!” is based on an interview with Emily Hamilton, MD, SVP of Clinical Research at PeriGen, Mary Veronica Daly, MD, Practicing Obstetrician at Lifeline Medical Group and Atlantic Health, and Robert B. Goley, SVP of Claims and Risk Management at MD Advantage.

Click here to read the rest of this article.